Influence on regulatory decisions for drugs with limited evidence [0.03%]
有限证据背景下新药审批的考量因素——基于监管机构立场的思考与建议
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani,Timothée Olivier
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani
Iain McGilchrist,Lucy Osler,Charlotte Blease
Iain McGilchrist
Matt Morgan
Matt Morgan
Jacob Carter,David Michaels,Wendy Wagner
Jacob Carter
Nicotine as a wellness product? The smoking alternatives being pushed by big tobacco [0.03%]
尼古丁也是保健产品？烟草巨头推新的替代烟品
Katharine Lang,Madeline Hutcheson
Katharine Lang
Melanie Penner,Lonnie Zwaigenbaum,Nicholas Piroddi et al.
Melanie Penner et al.
Autism is a neurodevelopmental condition with varied trajectories through the lifespan, leading to individualized patterns of strengths and challenges. Longitudinal autism cohort studies show the importance of developmental and adaptive ski...
Makoto Shiraishi
Makoto Shiraishi
DRC has strengthened its response to Ebola - but conflict and funding cuts are testing its capacity [0.03%]
刚果（金）已增强对埃博拉疫情的应对能力，但冲突与资金削减令其力有不逮
Aula Abbara,Michael Adeyemi Lawal
Aula Abbara